These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28779871)

  • 1. Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance.
    Riaz H; Khan AR; Khan MS; Rehman KA; Alansari SAR; Gheyath B; Raza S; Barakat A; Luni FK; Ahmed H; Krasuski RA
    Am J Cardiol; 2017 Sep; 120(5):774-781. PubMed ID: 28779871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y
    Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins Provide Less Benefit in Populations with High Noncardiovascular Mortality Risk: Meta-Regression of Randomized Controlled Trials.
    Kim CA; Kim DH
    J Am Geriatr Soc; 2015 Jul; 63(7):1413-9. PubMed ID: 26173475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
    Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
    BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
    Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
    Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.
    Teng M; Lin L; Zhao YJ; Khoo AL; Davis BR; Yong QW; Yeo TC; Lim BP
    Drugs Aging; 2015 Aug; 32(8):649-61. PubMed ID: 26245770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.
    Rahal AJ; ElMallah AI; Poushuju RJ; Itani R
    Saudi Med J; 2016 Oct; 37(10):1051-60. PubMed ID: 27652354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
    Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.
    Pertzov B; Eliakim-Raz N; Atamna H; Trestioreanu AZ; Yahav D; Leibovici L
    Clin Microbiol Infect; 2019 Mar; 25(3):280-289. PubMed ID: 30472427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for the primary prevention of cardiovascular disease in the elderly.
    Lowe RN; Vande Griend JP; Saseen JJ
    Consult Pharm; 2015 Jan; 30(1):20-30. PubMed ID: 25591028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials.
    Zhou Z; Albarqouni L; Breslin M; Curtis AJ; Nelson M
    BMJ Open; 2017 Sep; 7(9):e017587. PubMed ID: 28963307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials.
    Banach M; Serban C; Ursoniu S; Rysz J; Muntner P; Toth PP; Jones SR; Rizzo M; Glasser SP; Watts GF; Blumenthal RS; Lip GY; Mikhailidis DP; Sahebkar A;
    Pharmacol Res; 2015 Sep; 99():329-36. PubMed ID: 26192349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials.
    Banach M; Nikfar S; Rahimi R; Bielecka-Dabrowa A; Pencina MJ; Mikhailidis DP; Narkiewicz K; Rysz J; Ray KK; Abdollahi M;
    Int J Cardiol; 2013 Oct; 168(3):2816-24. PubMed ID: 23602289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.